Vistagen Therapeutics Inc (VTGN)
$3.52
0.00 (0.00%)
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q4 2024
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024.
Top 5 Stocks for 2024
![](https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif)
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
32.96M
PE Ratio
-2.32
EPS
-1.52
Volume (Avg. Vol.)
14
Day's Range
-
52-Week Range
$1.62 - $24.71
Dividend & Yield
N/A (N/A)